Cellular Tests for the Evaluation of Drug Hypersensitivity

2017 ◽  
Vol 22 (45) ◽  
pp. 6773-6783 ◽  
Author(s):  
Adriana Ariza ◽  
Maria Montanez ◽  
Tahia Fernandez ◽  
James Perkins ◽  
Cristobalina Mayorga
2008 ◽  
Vol 14 (27) ◽  
pp. 2803-2808 ◽  
Author(s):  
Maria Sanz ◽  
Pedro Gamboa ◽  
A. De Weck

Allergy ◽  
2002 ◽  
Vol 57 (1) ◽  
pp. 45-51 ◽  
Author(s):  
K. Brockow ◽  
A. Romano ◽  
M. Blanca ◽  
J. Ring ◽  
W. Pichler ◽  
...  

2021 ◽  
Vol 42 (1) ◽  
pp. 16-21 ◽  
Author(s):  
Anna R. Wolfson ◽  
Aleena Banerji

Immediate hypersensitivity to drugs is characterized by symptoms such as hives, swelling, and wheezing. To prevent a negative impact on care, assessment by an allergist is important. Evaluation requires a clear clinical history, but it is often lacking or vague, which makes a diagnosis difficult. Allergists instead can use skin testing and drug challenge to evaluate drug hypersensitivity reactions, which help the patient and provider understand the causative drug(s) and, more importantly, enables the use of the exonerated drug(s). Although penicillin skin testing is standardized, well described, and widely used, skin testing for most other drugs requires the use of a nonirritating skin testing concentration that can have a low negative predictive value. Drug challenges are the criterion standard for confirming tolerance. The allergist must obtain an in-depth clinical history and then follow with skin testing and/or drug challenges when indicated to determine which drugs can be de-labelled and which should be avoided. In this review, we focused on the evaluation of drug hypersensitivity reactions to antibiotics, perioperative agents, biologics, and chemotherapeutics.


2017 ◽  
Vol 22 (45) ◽  
pp. 6862-6869 ◽  
Author(s):  
Patrizia Bonadonna ◽  
Massimiliano Bonifacio ◽  
Roberta Zanotti

2019 ◽  
Vol 25 (36) ◽  
pp. 3840-3854 ◽  
Author(s):  
Hakan Guvenir ◽  
Tugba Arikoglu ◽  
Emine Vezir ◽  
Emine Dibek Misirlioglu

Drug hypersensitivity reactions are clinically heterogenous ranging from mild to severe. Most drug hypersensitivity reactions are accompanied by cutaneous manifestations. Fever, mucous membrane involvement, large blisters, facial oedema, pustulosis and visceral involvement are clinical features that lead to suspicion of severe adverse drug reactions. Severe cutaneous adverse drug reactions (SCARs) include Stevens-Johnson syndrome, toxic epidermal necrolysis, drug rash eosinophilia and systemic symptoms, acute generalized exanthematous pustulosis. Serum sickness like reactions, drug induced vasculitis and generalized bullous fixed drug eruptions are less severe clinical entities. SCARs are uncommon but associated with significant morbidity and mortality. Physician should be aware of specific red flags and danger signs to immediately identify these reactions. Immediate drug withdrawal is mandatory. Early diagnosis and appropriate treatment significantly affect the prognosis of the disease. The purpose of our review is to discuss clinical phenotypes of severe cutaneous drug hypersensitivity reactions.


Sign in / Sign up

Export Citation Format

Share Document